Search
Login
My Portfolios Login
TradeMachine® Login
CML Research Pro Login
Get TradeMachine®
Get CML Research
Compare Products
Home
My Portfolios
CMLViz News
Breaking
Stock
Scanner
Tear Sheet
News
Profile
Stats
Stock Chart
Pivot Points
Financial Charts
Holders
Analysts
Day Trader
Back-Tester
SPX
3,900.11
-14.04
(
-0.36%
)
Dow 30
-0.21%
QQQ
-0.72%
VIX
27.02
+0.07
(
+0.26%
)
Global Cord Blood Corp
NYSE:CO 3:59:50 PM EDT
3.19
-0.14
(
-4.20%
)
Products
Global Cord Blood Corporation Announced Cellenkos Receives FDA Clearance Of IND Application For CK0804
Published: 06/16/2022 21:24 GMT
CO
Global Cord Blood Corp (
CO
)
- Global Cord Blood Corporation Announced Cellenkos Receives FDA Clearance of Ind Application for Ck0804 As Add on Therapy to Ruxolitinib for the Treatment of Myelofibrosis.
